Loading...
XSTO
LINC
Market cap428mUSD
Jul 09, Last price  
71.50SEK
1D
2.14%
1Q
-4.28%
IPO
-32.16%
Name

Linc AB

Chart & Performance

D1W1MN
XSTO:LINC chart
P/E
—
P/S
426.69
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-1.17%
Rev. gr., 5y
49.23%
Revenues
10m
5,734,0004,633,0001,311,0004,138,0002,371,0003,650,00009,704,000
Net income
-400m
L
315,926,000596,179,000833,180,000-30,029,000-723,335,000619,459,0001,301,603,000-399,647,000
CFO
4m
-85.66%
-19,650,0001,174,000-14,626,000-353,839,000-228,147,000-80,569,00029,679,0004,255,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Linc AB operates as a private equity and venture capital firm, dedicating its investments to the pharmaceutical, life sciences, and med-tech sectors across early, mid, and late venture stages. The firm prioritizes investment opportunities within Nordic companies. Its typical investment amounts range from SEK 25 million to SEK 250 million, frequently beginning with a relatively smaller initial capital injection, with subsequent follow-up investments constituting the majority of its financial commitment. Linc AB's headquarters are located in Stockholm, Sweden.
URL
https://linc.se/
IPO date
May 28, 2021
Employees
2
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT